Linezolid

Is the active ingredient.

Treatment of communityacquired pneumonia (CAP)

Treatment of complicated skin and skin structure infections (cSSSI)

Treatment of vancomycinresistant enterococcus (VRE) infections

Treatment of hospitalacquired pneumonia (HAP)

Calinolid Iv 300ml (Linezolid) is a synthetic antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This prevents the formation of the initiation complex and subsequent peptide chain elongation, leading to bacterial cell death. It is effective against both Gram-positive and some Gram-negative bacteria.

Store at room temperature (20-25°C). Protect from moisture. Keep out of reach of children. Discard any unused medication after the expiration date.

Dosage varies depending on the infection and patient's condition. Always follow your doctor's instructions.

Typically administered orally or intravenously.

The duration of treatment depends on the severity of the infection and clinical response.

Nausea

Diarrhea

Headache

Vomiting

Thrombocytopenia (low platelet count)

Anemia

Peripheral neuropathy

Serotonin syndrome (rare but serious)

Lactic acidosis (rare but serious)

Hypersensitivity reactions (allergic reactions)

Alcohol Consumption

Avoid alcohol consumption during treatment as it can increase the risk of side effects.



While Driving or operating Machinery

Linezolid may cause dizziness or drowsiness. Avoid driving or operating machinery if affected.



Pregnant & Breastfeeding Women

Use only if clearly needed and under strict medical supervision. Discuss risks and benefits with your doctor.



Children

Use as directed by a physician; dosage may differ.



Kidney

Dose adjustment may be necessary in patients with impaired kidney function.



Liver

Dose adjustment may be necessary in patients with impaired liver function.

Your doctor or pharmacist

The official prescribing information (package insert)